[1] |
WANG Lin, YU Jianguo, LI Xiao, LUAN Jiajie.
Establish and implement a pre-prescription system for outpatient based on Six Sigma DMAIC model
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(7): 780-787.
|
[2] |
WANG Tiefeng, SU Jie, WANG Weidong, XIA Rongshuang, LI Sifan, ZHU Wenrui, LOU Zhaohuan.
Mechanisms of Radix Tetrastigma on anti rheumatoid arthritis via regulating the balance of Th17/Treg
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(2): 138-146.
|
[3] |
HE Jiaqi, LI Juanjuan, LV Xiaoai, ZHANG Huanhuan, YU Chenhuan.
Reversal effects and mechanisms of Flavonoids from Tetrastigma hemsleyanum on drug resistance in gefitinib-resistant lung cancer cells
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(4): 368-375.
|
[4] |
ZHOU Haiyan, WANG Kailing .
Resveratrol protects human retinal pigment epithelial cells from toxicity of high glucose by up-regulation of miR-26a
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(3): 285-292.
|
[5] |
YU Jing, ZHAO Hailan, CHENG Kaiyao, SHEN Pingyu, HUANG Jinlin.
Astragalus saponins inhibit high glucose-induced autophagy in human retinal pigment epithelial cells by regulating protein kinase R-like endoplasmic reticulum kinase pathway
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2019, 24(4): 361-368.
|
[6] |
SONG Xin, WANG Xue, ZHOU Huanghong, ZHAO Tianyi.
Effect of compound glycyrrhizin on the expression and clinical prognosis of antibacterial peptide LL-37 in patients with pigmentary purpuric skin disease
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2019, 24(4): 458-463.
|
[7] |
SONG Houpan, ZENG Meiyan, CHEN Xiaojuan, CHEN Xinyi, PENG Jun, ZHOU Yasha, YANG Yijing, YANG Tao, CAI Xiong, PENG Qinghua.
Molecular network regulation mechanism of Lycii Fructus in promoting directional differentiation of iris pigment epithelial cells to treat retinitis pigmentosa
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2019, 24(12): 1402-1414.
|
[8] |
LV Xiaojuan, TANG Weihong, WANG Huiting, WANG Zhongmin, GUAN Minchang, LI Haifeng.
Efficacy and safety analysis of fiberoptic bronchoscopy combined with methylprednisolone in children with RMPP
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2018, 23(9): 1040-1046.
|
[9] |
MENG Qiuhua, TIAN Jing, QIN Feizhang, QIN Yang, DONG Min.
Research progress of PD-1/PD-L1 pathway inhibitor in the immunotherapy of digestive system neoplasm
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2018, 23(8): 942-948.
|
[10] |
WANG Lu, LI Liping, XING Xin, XU Dengqiu, XIAO Li, JIANG Zhenzhou, ZHANG Luyong, SUN Lixin.
Hepatic macrophages in liver injury and repair
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2018, 23(10): 1188-1195.
|
[11] |
LU Wei, ZHOU Bingrong,TANG Yi, FAN Yibin, TAO Xiaohua.
Role of Th17 cells in acne pathogenesis and the correlation with severity of acne
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2018, 23(1): 83-87.
|
[12] |
RONG Guoyi, WANG Shumei, TANG Mo.
Efficacy of reducing phlegm with traditional Chinese medicine on non-small cell lung cancer: a Meta-analysis
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2017, 22(7): 787-794.
|
[13] |
YANG Zuqin, WANG Ying, CHEN Yingying.
Study on the adjuvant therapy of low birth weight infants with sepsis by IgM-rich immunoglobulin
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2017, 22(2): 174-178.
|
[14] |
WU Yanqin, JIANG Pei, TAN Qinyou, XU Ping, LI Huande, CAI Hualin.
Research advance of central σ-2 receptor on the pathogenesis and therapeutics of neuropsychiatric diseases
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2017, 22(2): 210-214.
|
[15] |
ZHONG Liangrui, CHEN Hua, JING Jing, QIAO Hongli, WEI Kemin, WANG Weidong.
Radix tetrastigma hemsleyani flavone suppresses human lung carcinoma A549 cell via proteasome inhibition
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2017, 22(10): 1123-1126.
|